NEWS – Acceleration Program Spring 2025 Startups have been selected!
After an intensive selection process, we’re delighted to unveil the participants of the Spring 2025 edition of our Acceleration Program. We eagerly anticipate accompanying these 10 exceptional pre-seed startups selected over the next weeks and supporting them as they embark on their entrepreneurial journey. A warm welcome from the Bluelion Community to all startups!

sign.mt
Sign.mt is an open-source application designed to facilitate real-time, bidirectional translation between spoken and signed languages.
Atenia AI
Atenia AI is developing a Digital Infrastructure engineer that automates the end-to-end workflow of software infrastructure management.
DATABIOMIX
DATABIOMIX leverages a one-stop shop for fast and high-resolution microbiota biomarker discovery, microbial screenings, and microbiome-based diagnostic assay development.
UTHEREAL.ai
UTHEREAL.ai helps experts build AI Co-Pilots systems.
InsightSphere
InsightSphere empowers employees to present and sell with confidence. They offer VR presentation skills training and a personalized sales simulation.
Winduction
Winduction revolutionizes EV charging solutions by developing an efficient and safe wireless power transfer technology that integrates seamlessly into the existing road infrastructure.
Skriba
Skriba is an AI-powered collaborative tool that enables Swiss companies to create qualified interim and employment references 10 times faster, ensuring legal compliance and multilingual support.
UpGrid
UpGrid’s platform empowers energy communities to co-own, share, and store clean energy. We’re building thedigital backbone of tomorrow’s grid: local, connected, and smart.
PermeaSense
PermeaSense is a plug-and-play microfluidic platform that maps real-time drug penetration into biofilms, accelerating the development of effective anti-biofilm treatments.
Rekonas GmbH
Rekonas mask-free home therapy treats sleep apnea without uncomfortable face masks. They save costs by phenotyping patients first, and identifying ideal candidates before treatment begins.